GHST World Inc. (GHST)

Intra-Cellular Therapies Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	0	0.02	0.04	0	0.01	0
Cash & Short-Term Investments	0	0.02	0.04	0	0.01	0
Cash Growth	89.47%	-53.66%	19072.33%	-97.20%	2417.12%	-86.00%
Accounts Receivable	0	0	-	-	-	-
Receivables	0	0	-	-	-	-
Total Current Assets	0	0.02	0.04	0	0.01	0
Long-Term Deferred Charges	-	-	-	-	0.04	0.03
Other Long-Term Assets	-	-	-	-	0.12	0.12
Total Assets	0	0.02	0.04	0	0.16	0.15
Accounts Payable	0	0.01	0	0	0.01	0.01
Short-Term Debt	0.4	0.28	0.14	0.1	0.02	0.1
Current Unearned Revenue	-	0.04	0.02	-	-	-
Other Current Liabilities	-	-	-	-	0.22	0.15
Total Current Liabilities	0.4	0.33	0.16	0.1	0.25	0.26
Total Liabilities	0.4	0.33	0.16	0.1	0.25	0.26
Common Stock	0.13	0.13	0.13	0.12	0.01	0.4
Additional Paid-In Capital	13.44	13.44	13.12	13.03	9.17	8.61
Retained Earnings	-13.97	-13.88	-13.37	-13.25	-9.27	-9.12
Total Common Equity	-0.4	-0.31	-0.12	-0.1	-0.09	-0.11
Shareholders' Equity	-0.4	-0.31	-0.12	-0.1	-0.09	-0.11
Total Liabilities & Equity	0	0.02	0.04	0	0.16	0.15
Total Debt	0.4	0.28	0.14	0.1	0.02	0.1
Net Cash (Debt)	-0.4	-0.26	-0.1	-0.1	-0.01	-0.1
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.03
Filing Date Shares Outstanding	130.2	130.2	130.2	124.43	5.29	3.98
Total Common Shares Outstanding	130.2	130.2	125.73	124.43	5.24	3.98
Working Capital	-0.4	-0.31	-0.12	-0.1	-0.24	-0.26
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.02	-0.03
Tangible Book Value	-0.4	-0.31	-0.12	-0.1	-0.09	-0.11
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.02	-0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.